We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current COEPW market cap is 726.5k. The company's latest EPS is USD -0.6235 and P/E is -19.17.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -34.2M | -6.45M | -3.6M | -7.81M | -3.63M |
| Net Income | -40.25M | -7.87M | -3.11M | -6.26M | -4.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2k | -68k | -681k | -34.2M | -21.49M |
| Net Income | -2k | -67k | 15.23M | -37.57M | -21.27M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.92M | 5.94M | 7.16M | 7.17M | 8.07M |
| Total Liabilities | 3.11M | 4.66M | 4.67M | 2.16M | 3.76M |
| Total Equity | 4.8M | 1.29M | 2.49M | 5.01M | 4.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 172k | 76.71M | 76.17M | 7.92M | 8.07M |
| Total Liabilities | 156k | 2.26M | 7.19M | 3.11M | 3.76M |
| Total Equity | 16k | 5M | -6.77M | 4.8M | 4.31M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.88M | -1.68M | -3.59M | -5.55M | -7.24M |
| Investing | N/A | N/A | -350k | N/A | N/A |
| Financing | 5.49M | N/A | 3.39M | 3.17M | 4.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2k | -116k | -503k | -3.88M | -7.24M |
| Investing | N/A | -75.75M | N/A | N/A | N/A |
| Financing | 2k | 76.77M | N/A | 5.49M | 4.92M |
| Market Cap | 726.5k |
| Price to Earnings Ratio | -19.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 277.26 |
| Price to Book Ratio | 94.48 |
| Dividend Yield | - |
| Shares Outstanding | 34.11M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (46.48%) |
| Company Name | Coeptis Therapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.coeptistx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
